title: "Lead hopping". Validation of topomer similarity as a superior predictor of similar biological activities.
abstract: Two extensive studies quantifying the ability of topomer shape similarity to forecast a variety of biological similarities are described. In a prospective trial of "lead hopping", using topomer similarity for virtual screening and queries from the patent literature, biological assays of 308 selected compounds (representing 0.03% of those available, per assay type) yielded 11 successful "lead hops" in the 13 assays attempted. The hit rate averaged over all assays was 39% ("activity"defined as inhibition > or =20% at 10 microM), significantly greater than an unexpectedly high negative control hit rate of 15%. The average "Tanimoto 2D fingerprint similarity" between query and "lead hop" structures (0.36) was little more than the Tanimoto similarity between random drug-like structures. Topomer shape and Tanimoto 2D fingerprint similarities were also compared retrospectively, in their tendencies to concentrate together potential and actual drugs reported to belong to the same "activity class", for twenty classes. Among the most similar 3% of structures (corresponding to "> or =0.85 Tanimoto" for these structures), an average of 62% of the topomer similar selection possessed a near neighbor belonging to the same activity class, roughly a one-third superiority over the "Tanimoto > or = 0.85" selection containing 48% actives in avoiding false positives. Conversely, the least similar 75% of structures contained 0.3% actives for topomer similarity vs 1.0% actives for Tanimoto 2D fingerprint similarity, a 3-fold superiority for topomers in avoiding false negatives.
authors.affiliation: Tripos Discovery Research, Bude-Stratton Business Park, Bude, Cornwall EX23 8LY, UK. cramer@tripos.com
authors.forename: Richard D
authors.initials: RD
authors.lastname: Cramer
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Jilek
authors.forename: Stefan
authors.initials: S
authors.lastname: Guessregen
authors.forename: Stephanie J
authors.initials: SJ
authors.lastname: Clark
authors.forename: Bernd
authors.initials: B
authors.lastname: Wendt
authors.forename: Robert D
authors.initials: RD
authors.lastname: Clark
mesh_terms: D003205:Computing Methodologies; D015195:Drug Design; D018716:Molecular Mimicry; D015394:Molecular Structure; D013329:Structure-Activity Relationship